Polycystic ovary syndrome: Symptomatology, pathophysiology, and epidemiology

American Journal of Obstetrics and Gynecology

Volumn 179, Issue 6 II, 1998, Pages

  Guzick, D ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Cardiovascular risk; Epidemiology; Polycystic ovary syndrome

Indexed keywords

CHOLESTEROL; GESTAGEN; HIGH DENSITY LIPOPROTEIN; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; LUTEINIZING HORMONE; ORAL CONTRACEPTIVE AGENT; SPIRONOLACTONE; TRIACYLGLYCEROL;

ACNE; AMENORRHEA; ARTICLE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; EPIDEMIOLOGY; FEMALE; FEMALE INFERTILITY; HIRSUTISM; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; MENSTRUATION DISORDER; OBESITY; ORAL DRUG ADMINISTRATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; SYMPTOMATOLOGY; VIRILIZATION;

EID: 0032436041     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9378(98)70238-8     Document Type: Article

References (20)

1. JK Zawedzki A Dunaif Diagnostic criteria for polycystic ovary syndrome: towards a rational approach A Dunaif JR Givens FP Haseltine GR Merriam Polycystic ovary syndrome 1992 Blackwell Scientific Boston 377 384
2. JW Goldzieher JA Green Clinical and biochemical features of polycystic ovarian disease Fertil Steril 14 1963 631 653
3. S Franks Polycystic ovary syndrome N Engl J Med 333 1989 853 861
4. MG Hammond JK Halme LM Talbert Factors affecting the pregnancy rate in clomiphene citrate induction of ovulation Obstet Gynecol 62 1983 196 202
5. SS Yen C Cheney HL Judd Functional aberrations of the hypothalamic-pituitary system in polycystic ovary syndrome VH James TM Serio G Guiti The endocrine function of the human ovary 1976 Academic Press New York 373 385
6. RJ Chang RM Nakamura HL Judd SA Kaplan Insulin resistance in nonobese patients with polycystic ovarian disease J Clin Endocrinol Metab 57 1983 356 359
7. A Dunaif KR Segal W Futtereweit A Drobrjansky Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome Diabetes 38 1989 1165 1174
8. GA Burghen JR Givens AE Kitabchi Correlation of hyperandrogenism with hyperinsulinemia in polycystic ovarian disease J Clin Endocrinol Metab 50 1980 113 115
9. ME Geffner SA Kaplan N Bersch DW Golde EM Landaw RJ Chang Persistence of insulin resistance in polycystic ovarian disease after inhibition of ovarian steroid secretion Fertil Steril 45 1986 327 333
10. JE Nestler CO Barlascinik DW Matt KA Steingold SR Plymate JN Clore Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome J Clin Endocrinol Metab 68 1989 1027 1032
11. RB Barnes RL Rosenfield S Burstein DA Ehrmann Pituitary-ovarian responses to nafaralin testing in the polycystic ovary syndrome N Eng J Med 320 1989 559 565
12. α as the cause of polycystic ovary syndrome. Fertil Steril 190;53:785-91.
13. SL Berga TL Daniels Use of the laboratory in disorders of reproductive neuroendocrinology J Clin Immunoassay 14 1991 23 28
14. DA Ehrmann RB Barnes RL Rosenfield Hyperandrogenism, hirsutism and the polycystic ovary syndrome 3rd ed LJ De Groot Endocrinology vol 3 1994 WB Saunders Philadelphia 2093 2112
15. D DeWailly C Cortet-Rudelli D Deroubaix-Allard Definition, clinical manifestations and prevalence of PCOS R Assiz JE Nestler D DeWailly Androgen excess disorders in women 1997 Lippincott-Raven Philadelphia 259 268
16. E Dahlgren P Janson S Johansson L Mattson G Lindstet N Crona Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones Fertil Steril 57 1992 505 513
17. E Dahlgren P Janson S Johansson L Lapidus A Oden Polycystic ovary syndrome and risk for myocardial infarction: evaluated from a risk factor model based on a prospective population study of women Acta Obstet Gynecol Scand 71 1992 599 604
18. RA Wild MJ Bartholomew The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome Am J Obstet Gynecol 159 1988 423 427
19. E Talbott D Guzick A Clerici S Berga K Detre K Weimer Coronary heart disease risk factors in women with polycystic ovary syndrome Art Thromb Vasc Biol 15 1995 821 826
20. DS Guzick E Talbott K Sutton-Tyrrell H Herzog L Kuller S Wolfson Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study Am J Obstet Gynecol 174 1996 1224 1232